N. Anthony Coles, CEO and Chairperson at Cerevel Therapeutics Holdings, Inc. (CERE), sold 50,000 shares at $27.11 ($1.4M) on 2023-03-02, disclosed to the SEC on 2023-03-06.
Open-market sale of $1.4M CERE by CEO and Chairperson. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.11 | 47,000 | $1.3M | 94.0% |
| 2 | $27.19 | 3,000 | $82K | 6.0% |
| Total | $27.11 avg | 50,000 | $1.4M | 100% |
| Filing → |
| CERE | SELL | 2024-05-14 | $2.1M | — | Filing → |
| CERE | SELL | 2024-04-03 | $2.1M | — | Filing → |
| CERE | SELL | 2024-03-06 | $2.1M | — | Filing → |